about
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS.Rapid MALDI-TOF-MS analysis in the study of interaction between whole bacterial cells and human target molecules: binding of Bifidobacterium to human plasminogen.Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach.Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry.Mass spectrometry as an efficient tool for the characterization of amyloid β peptide 25-35 self-assembly species in aggregation and inhibition studies.Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors.Bright oligothiophene N-succinimidyl esters for efficient fluorescent labeling of proteins and oligonucleotides.Quinazoline based α1-adrenoreceptor antagonists with potent antiproliferative activity in human prostate cancer cell lines.Direct determination of GSK-3β activity and inhibition by UHPLC-UV-vis diode arrays detector (DAD).Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis.Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule.Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.UHPLC determination of catechins for the quality control of green tea.A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field.Structural basis for the magnesium-dependent activation of transketolase from Chlamydomonas reinhardtii.Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress.Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis.Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes.Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer.Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases.Immobilized enzyme-based analytical tools in the -omics era: Recent advancesExploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's DiseaseA patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017Isolation and Characterization of Wheat Derived Nonspecific Lipid Transfer Protein 2 (nsLTP2)Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitisPosttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosisNew insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopyBright OligothiopheneN-Succinimidyl Esters for Efficient Fluorescent Labeling of Proteins and OligonucleotidesDesign, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitorsDiscovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatmentPolycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities
P50
Q33319847-1CDDFA33-52C1-41BA-BF57-5B45D6112666Q33330559-FC7C5934-BC41-438A-A559-6D46FDF233CEQ33855016-7CD4760B-06D4-4C99-BCA1-0DEB0D2E553BQ34409540-76247110-5C6D-4606-99CF-887DDB558BB3Q35078911-8FA94650-5B8A-4822-A997-F09890A1C8D9Q36299645-67EEC690-9CE3-40AC-993B-1E5B57345D37Q38316745-4180EB75-3C98-4727-8242-77F3192C5BC1Q38703684-4D60638B-40E1-40D8-8FF7-2AD15C16CE3AQ39948572-525C60E0-D6DB-40E0-937D-E0334D8CDB91Q40248123-DF00B513-30EC-4511-92BC-3C9BA454B43FQ41260673-BA4E6A72-296E-40BC-B85F-0381C93FC359Q41581883-C99DE9ED-A3E5-4707-AA30-0D8A542DEE54Q41664110-F2BDC429-901B-4FD7-8C57-B2AB658501F2Q43660657-AA10F537-B90E-4B89-9EB1-A843A23842CCQ45799435-74A05704-4D4F-46B7-AA07-F211F9C22FA6Q50200958-7CECA496-A8FB-416B-8A20-7EF0D44F41EAQ50253316-DA5A073A-9AC4-4828-B4F8-7BE84EC409B6Q51086547-8432B16F-F302-45AB-8A41-C6DDE36D1942Q52893904-C46A3505-9C55-4A3D-B23D-36A01119CD55Q53155935-1607D584-CC0A-4B7C-9249-C2E481C9DF5CQ53652444-54073315-6E57-436F-AC2A-EA3E0189F96BQ56360524-7FFFF8E0-5C9F-49CA-92E7-9AA0915EEA8EQ56361601-C096F604-DEFD-44EB-BAA2-9156F3AFF9BFQ56380193-51731F36-0392-4FB2-BE30-FFE5796A1F48Q56380450-38C86BB4-ED0B-4E29-AE57-9F756EDA1ABEQ56965372-6D01FB42-CE2B-41F0-A35B-7E6BEC92D562Q56972064-F622017A-C42E-44C5-8AE0-71FFE3BC0236Q58010745-A1739CAE-DC9E-4AF9-A5CC-378EB669D13FQ63253241-546F1A84-C772-4AAB-879D-5B1E8C4E2166Q91858077-0A3D2901-19DC-4217-9126-B6A3FF860C7BQ92382915-18F5F338-D656-4C08-892B-3BD4F1618214Q92660389-45EDDC39-F37F-40C6-A2ED-807973127F09Q93166788-ACB78C17-8520-49D2-8FF1-293E38CBF279
P50
description
investigador
@es
researcher
@en
name
Marina Naldi
@en
type
label
Marina Naldi
@en
altLabel
Naldi M
@en
prefLabel
Marina Naldi
@en
P31
P496
0000-0003-4468-2974